Three Madison businesses gets SBIR grants

Three Madison businesses, including Proteovista LLC, are among eight Wisconsin ventures to receive matching grants to commercialize their innovations as part of the Small Business Innovation Research Advance program.

Proteovisa, which makes drug discovery assays and personalized medicinal research tools, received a Phase I grant. The support will help the company bring to market its tools, which can display the full human genome or proteome on a single glass chip.

Meanwhile, two Madison companies, DataChat and NCD Technologies, received Phase II grants.

DataChat is developing an analytics platform that allows business users to “self-serve” complex analytics pipelines by conversing with DataChat English.

NCD Technologies engineers and optimizes a diamond-like carbon coating so that the U.S. Army can prevent the formation of lethal toxic gas, thereby improving the shelf-life performance of obscurant munitions.

A total of $674,000 in state matching grants were awarded to advance eight high-tech small businesses statewide, with four Phase I winners getting between $49,000 to $75,000 each, and four Phase II businesses receiving up to $100,000.

The state matching grant program provides assistance to companies in the process of completing a project in the federal Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) programs.

This is the 14th round of SBIR Advance funding since this collaboration by the Wisconsin Economic Development Corp. and the University of Wisconsin System Administration’s Center for Technology Commercialization began in 2014.

Since 2014, 96 awards have been given, equaling nearly $7.4 million, to businesses in 18 communities throughout the state.

Those businesses reported hiring more than 180 employees and obtaining over $29.5 million in additional capital since receiving the grants.